Literature DB >> 16584294

Evaluation of transfection protocols for unmodified and modified peptide nucleic acid (PNA) oligomers.

Frank Winther Rasmussen1, Nadia Bendifallah, Vladimir Zachar, Takehiko Shiraishi, Trine Fink, Peter Ebbesen, Peter E Nielsen, Uffe Koppelhus.   

Abstract

We have compared the efficacy of different transfection protocols reported for peptide nucleic acid (PNA) oligomers. A precise evaluation of uptake efficacy was achieved by using a positive readout assay based on the ability of a PNA oligomer to correct aberrant splicing of a recombinant luciferase gene. The study comprised transfection of PNA conjugated to acridine, adamantyl, decanoic acid, and porphyrine (acr-PNA, ada-PNA, deca-PNA, and por-RNA, respectively) and unmodified PNA partially hybridized to a DNA oligomer (PNA/DNA cotransfection). Furthermore, the effect of conjugation to a nuclear localization signal (NLS) was evaluated as part of the PNA/DNA cotransfection protocol. Transfection of the tested PNAs was systematically optimized. PNA/DNA cotransfection was found to produce the highest luciferase activity, but only after careful selection of the DNA oligonucleotide. Both a cationic lipid, Lipofectamine, and a nonliposomal cationic polymer, polyethylenimine (PEI, ExGen 500), were efficient transfection reagents for the PNA/DNA complex. However, Lipofectamine, in contrast to PEI, showed severe side effects, such as cytotoxicity. acr-PNA, ada-PNA, and por-PNA were transfectable with efficacies between 5 and 10 times lower than that seen with PNA/DNA cotransfection. Conjugation of PNA to NLS had no effect on PNA/DNA cotransfection efficacy. An important lesson from the study was the finding that because of uncontrollable biologic variations, even optimal transfection conditions differed to a certain extend from experiment to experiment in an unpredictable way.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16584294     DOI: 10.1089/oli.2006.16.43

Source DB:  PubMed          Journal:  Oligonucleotides        ISSN: 1545-4576


  12 in total

1.  INTERCALATING CONJUGATES OF PEG WITH NUCLEAR LOCALIZATION SIGNAL (NLS) PEPTIDE.

Authors:  Serguei V Vinogradov; Hongwei Zhang; Anton Mitin; Galya Warren
Journal:  Polymer Prepr       Date:  2008

2.  Delivery of Peptide Nucleic Acids Using an Argininocalix[4]arene as Vector.

Authors:  Alessia Finotti; Jessica Gasparello; Alessandro Casnati; Roberto Corradini; Roberto Gambari; Francesco Sansone
Journal:  Methods Mol Biol       Date:  2021

Review 3.  Controlling subcellular delivery to optimize therapeutic effect.

Authors:  Mohanad Mossalam; Andrew S Dixon; Carol S Lim
Journal:  Ther Deliv       Date:  2010-07

4.  Cationic shell-cross-linked knedel-like (cSCK) nanoparticles for highly efficient PNA delivery.

Authors:  Huafeng Fang; Ke Zhang; Gang Shen; Karen L Wooley; John-Stephen A Taylor
Journal:  Mol Pharm       Date:  2009 Mar-Apr       Impact factor: 4.939

5.  Antisense peptide nucleic acid-functionalized cationic nanocomplex for in vivo mRNA detection.

Authors:  Yuefei Shen; Ritu Shrestha; Aida Ibricevic; Sean P Gunsten; Michael J Welch; Karen L Wooley; Steven L Brody; John-Stephen A Taylor; Yongjian Liu
Journal:  Interface Focus       Date:  2013-06-06       Impact factor: 3.906

6.  Phospholipid conjugate for intracellular delivery of peptide nucleic acids.

Authors:  Gang Shen; Huafeng Fang; Yinyin Song; Agata A Bielska; Zhenghui Wang; John-Stephen A Taylor
Journal:  Bioconjug Chem       Date:  2009-09       Impact factor: 4.774

7.  Effective delivery of antisense peptide nucleic acid oligomers into cells by anthrax protective antigen.

Authors:  Daniel G Wright; Ying Zhang; John R Murphy
Journal:  Biochem Biophys Res Commun       Date:  2008-09-05       Impact factor: 3.575

8.  Targeting pre-miRNA by peptide nucleic acids: a new strategy to interfere in the miRNA maturation.

Authors:  Concetta Avitabile; Michele Saviano; Luca D'Andrea; Nicoletta Bianchi; Enrica Fabbri; Eleonora Brognara; Roberto Gambari; Alessandra Romanelli
Journal:  Artif DNA PNA XNA       Date:  2012-04-01

Review 9.  Peptide-mediated cellular delivery of oligonucleotide-based therapeutics in vitro: quantitative evaluation of overall efficacy employing easy to handle reporter systems.

Authors:  S D Laufer; T Restle
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

10.  Peptide-mediated Cell and In Vivo Delivery of Antisense Oligonucleotides and siRNA.

Authors:  Peter Järver; Thibault Coursindel; Samir El Andaloussi; Caroline Godfrey; Matthew Ja Wood; Michael J Gait
Journal:  Mol Ther Nucleic Acids       Date:  2012-06-12       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.